Skip to content
Non-Current Assets

Goodwill

Guardant Health Goodwill remained flat by 0.0% to $77.26M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2248.2%, from $3.29M to $77.26M. Over 5 years (FY 2020 to FY 2025), Goodwill shows an upward trend with a 88.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2018
Last reportedQ1 2026May 7, 2026

How to read this metric

An increase indicates recent M&A activity, while a decrease often signals an impairment charge due to underperforming acquisitions.

Detailed definition

Goodwill represents the premium paid over the fair market value of net identifiable assets during an acquisition. It ref...

Peer comparison

Varies widely based on M&A history; high levels relative to equity may indicate risk of future impairment.

Metric ID: goodwill

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$3.29M$77.26M$77.26M
QoQ Change+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%>999%+0.0%
YoY Change+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%>999%>999%
Range$3.29M$77.26M
CAGR+94.3%
Avg YoY Growth+281.0%
Median YoY Growth+0.0%
Current Streak19+ quarters growth

Frequently Asked Questions

What is Guardant Health's goodwill?
Guardant Health (GH) reported goodwill of $77.26M in Q1 2026.
How has Guardant Health's goodwill changed year-over-year?
Guardant Health's goodwill increased by 2248.2% year-over-year, from $3.29M to $77.26M.
What is the long-term trend for Guardant Health's goodwill?
Over 5 years (2020 to 2025), Guardant Health's goodwill has grown at a 88.0% compound annual growth rate (CAGR), from $3.29M to $77.26M.
What does goodwill mean?
The excess purchase price paid for an acquired company over the value of its individual assets.